AI Article Synopsis

  • Nonadherence to treatment is a significant issue in managing major depressive disorder (MDD), and this study explores how various symptoms impact this issue based on a nationwide survey in China.
  • The research involved 1,739 participants diagnosed with MDD who underwent a detailed questionnaire to evaluate their symptoms, employing logistic regression to analyze adherence factors.
  • Findings indicate that certain elements, like recurrent episodes and specific antidepressant treatments, increase the likelihood of nonadherence, while others, like using SNRIs, can help protect against it, suggesting that clinicians should focus on these characteristics to improve treatment compliance.

Article Abstract

Aims: Nonadherence is one of the leading challenges to treatment of the major depressive disorder (MDD). Few studies have systematically analyzed the relationship between clinical characteristics, especially symptoms of depressive patients and their therapeutic nonadherence over a relatively large sample. This study aimed to investigate factors of nonadherence in a nationwide survey in China.

Methods: Participants with MDD who met the criteria of Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV) were recruited from 32 sites throughout China. Patients were all over 16 years old. A doctor-rating questionnaire with 64 symptoms based on DSM-IV was constructed to evaluate depression-related feeling and behavior. Single-factor logistic regression was utilized to screen variables, and multifactor logistic regressive analysis was used to identify which factors were risk or protective for nonadherence. We included 882 patients of poor adherence and 857 patients of good adherence.

Results: Recurrence, untreated first episode, tricyclic antidepressant (TCA)-treated first episode, antidepressant-only-treated current episode, decrease or loss of interest, more somatic symptoms, and "atypical" symptoms were risk factors for nonadherence, whereas selective noradrenaline reuptake inhibitor (SNRI)-treated first episode was a protecting factor.

Conclusion: Clinical characteristics may play an important role in predicting nonadherence. Doctors may have to pay much attention on patients with these factors and should keep on discussing them with patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488920PMC
http://dx.doi.org/10.1111/cns.13030DOI Listing

Publication Analysis

Top Keywords

clinical characteristics
12
therapeutic nonadherence
8
major depressive
8
depressive disorder
8
factors nonadherence
8
nonadherence
7
patients
7
characteristics associated
4
associated therapeutic
4
nonadherence patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!